Abstract
Streptomycetes remain as one of the important sources for bioactive products. Isolated from the mangrove forest, Streptomyces gilvigriseus MUSC 26(T) was previously characterised as a novel streptomycete. The high quality draft genome of MUSC 26(T) contained 5,213,277bp with G+C content of 73.0%. Through genome mining, several gene clusters associated with secondary metabolites production were revealed in the genome of MUSC 26(T). These findings call for further investigations into the potential exploitation of the strain for production of pharmaceutically important compounds.